Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
ACS Nano ; 17(7): 6575-6588, 2023 04 11.
Artículo en Inglés | MEDLINE | ID: mdl-36802500

RESUMEN

In prion diseases, fibrillar assemblies of misfolded prion protein (PrP) self-propagate by incorporating PrP monomers. These assemblies can evolve to adapt to changing environments and hosts, but the mechanism of prion evolution is poorly understood. We show that PrP fibrils exist as a population of competing conformers, which are selectively amplified under different conditions and can "mutate" during elongation. Prion replication therefore possesses the steps necessary for molecular evolution analogous to the quasispecies concept of genetic organisms. We monitored structure and growth of single PrP fibrils by total internal reflection and transient amyloid binding super-resolution microscopy and detected at least two main fibril populations, which emerged from seemingly homogeneous PrP seeds. All PrP fibrils elongated in a preferred direction by an intermittent "stop-and-go" mechanism, but each population possessed distinct elongation mechanisms that incorporated either unfolded or partially folded monomers. Elongation of RML and ME7 prion rods likewise exhibited distinct kinetic features. The discovery of polymorphic fibril populations growing in competition, which were previously hidden in ensemble measurements, suggests that prions and other amyloid replicating by prion-like mechanisms may represent quasispecies of structural isomorphs that can evolve to adapt to new hosts and conceivably could evade therapeutic intervention.


Asunto(s)
Proteínas Priónicas , Priones , Proteínas Priónicas/genética , Proteínas Priónicas/metabolismo , Cinética , Priones/química , Amiloide/química , Proteínas Amiloidogénicas
2.
J Mol Biol ; 435(15): 168158, 2023 08 01.
Artículo en Inglés | MEDLINE | ID: mdl-37244570

RESUMEN

In prion replication, the cellular form of prion protein (PrPC) must undergo a full conformational transition to its disease-associated fibrillar form. Transmembrane forms of PrP have been implicated in this structural conversion. The cooperative unfolding of a structural core in PrPC presents a substantial energy barrier to prion formation, with membrane insertion and detachment of parts of PrP presenting a plausible route to its reduction. Here, we examined the removal of residues 119-136 of PrP, a region which includes the first ß-strand and a substantial portion of the conserved hydrophobic region of PrP, a region which associates with the ER membrane, on the structure, stability and self-association of the folded domain of PrPC. We see an "open" native-like conformer with increased solvent exposure which fibrilises more readily than the native state. These data suggest a stepwise folding transition, which is initiated by the conformational switch to this "open" form of PrPC.


Asunto(s)
Proteínas Priónicas , Humanos , Proteínas Priónicas/química , Proteínas Priónicas/genética , Conformación Proteica en Lámina beta , Pliegue de Proteína
3.
Commun Biol ; 3(1): 402, 2020 07 29.
Artículo en Inglés | MEDLINE | ID: mdl-32728168

RESUMEN

Prion diseases, a group of incurable, lethal neurodegenerative disorders of mammals including humans, are caused by prions, assemblies of misfolded host prion protein (PrP). A single point mutation (G127V) in human PrP prevents prion disease, however the structural basis for its protective effect remains unknown. Here we show that the mutation alters and constrains the PrP backbone conformation preceding the PrP ß-sheet, stabilising PrP dimer interactions by increasing intermolecular hydrogen bonding. It also markedly changes the solution dynamics of the ß2-α2 loop, a region of PrP structure implicated in prion transmission and cross-species susceptibility. Both of these structural changes may affect access to protein conformers susceptible to prion formation and explain its profound effect on prion disease.


Asunto(s)
Enfermedades por Prión/genética , Proteínas Priónicas/genética , Priones/genética , Conformación Proteica , Animales , Humanos , Mutación Puntual/genética , Enfermedades por Prión/patología , Proteínas Priónicas/ultraestructura , Priones/ultraestructura , Conformación Proteica en Lámina beta/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA